CIK 0001773751 · Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,052,782
- in 14 filings, $4.1M under 10b5-1 plans
Net −$4,052,782. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Payne Christopher D Director | Grant or award · Restricted Stock Unit | +810 | 810 | ||
| 2026-11-11 | Franklin Jonathan M Chief Accounting Officer | Grant or award · Restricted Stock Unit | +102,774 | 102,774 | ||
| 2026-11-11 | WELLS DAVID B Director | Grant or award · Restricted Stock Unit | +1,051 | 1,051 | ||
| 2026-11-11 | Huberman Andrew D Director | Grant or award · Restricted Stock Unit | +14,020 | 14,020 | ||
| 2026-11-11 | Huberman Andrew D Director | Grant or award · Restricted Stock Unit | +5,281 | 5,281 | ||
| 2026-10-28 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −3,462 | $27.60 | $96K | 293,886 |
| 2026-10-14 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −3,461 | $29.06 | $101K | 297,348 |
| 2026-10-01 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −2,000 | $29.70 | $59K | 234,527 |
| 2026-09-30 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −3,461 | $29.17 | $101K | 300,809 |
| 2026-09-22 | Okupe Oluyemi Chief Financial Officer | Option exercise 10b5-1 | +14,000 | $5.01 | $70K | 265,804 |
| 2026-09-22 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −29,277 | $29.95 | $877K | 236,527 |
| 2026-09-22 | Okupe Oluyemi Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −14,000 | 66,872 | ||
| 2026-09-17 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −12,313 | $28.82 | $355K | 251,804 |
| 2026-09-16 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −6,236 | $27.86 | $174K | 304,270 |
| 2026-09-15 | Elshenawy Mohamed CTO | Sale 10b5-1 | −7,954 | $28.39 | $226K | 185,556 |
| 2026-09-15 | Chi Michael Chief Operating Officer | Sale 10b5-1 | −14,027 | $28.39 | $398K | 456,660 |
| 2026-09-02 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −3,458 | $28.33 | $98K | 310,506 |
| 2026-08-27 | Dudum Andrew Chief Executive Officer | Other disposition | −977,566 | 103,406 | ||
| 2026-08-25 | Dudum Andrew Chief Executive Officer | Gift | −463,289 | 0 | ||
| 2026-08-19 | Okupe Oluyemi Chief Financial Officer | Option exercise 10b5-1 | +4,938 | $5.01 | $25K | 269,055 |
Page 1 of 15 · 296 trades